Genflow Biosciences PLC (GENF)

Currency in GBP
2.03
+0.02(+1.00%)
Closed·
GENF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.962.06
52 wk Range
0.553.12
Key Statistics
Bid/Ask
1.90 / 2.30
Prev. Close
2.03
Open
2.03
Day's Range
1.96-2.06
52 wk Range
0.55-3.12
Volume
183.06K
Average Volume (3m)
1.67M
1-Year Change
170%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Genflow Biosciences PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-- / --
Revenue / Forecast
585.61K / --
EPS Revisions
Last 90 days

GENF Income Statement

Compare GENF to Peers and Sector

Metrics to compare
GENF
Peers
Sector
Relationship
P/E Ratio
−8.1x−6.7x−0.4x
PEG Ratio
−0.27−0.010.00
Price/Book
−20.9x3.4x2.6x
Price / LTM Sales
19.6x5.5x3.0x
Upside (Analyst Target)
-150.8%51.9%
Fair Value Upside
Unlock−13.0%9.4%Unlock

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States. It develops drugs in pre-clinical trial stage, including GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion for the treatment of metabolic associated steatohepatitis; GF-1003, a topical delivery of SIRT6 to the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005 for the treatment of mitochondrial dysfunction and sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company was founded in 2020 and is headquartered in London, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
181.13M31.98%3.67M
Public Companies & Retail Investors
385.28M68.02%7.80M
Total
566.41M100.00%11.47M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Aberdeen Group Plc8.43%47,758,252967
Hargreaves Lansdown Asset Management Ltd.7.28%41,218,000835

FAQ

What Is the Genflow Biosciences (GENF) Stock Price Today?

The Genflow Biosciences stock price today is 2.03 GBP.

What Stock Exchange Does Genflow Biosciences Trade On?

Genflow Biosciences is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Genflow Biosciences?

The stock symbol for Genflow Biosciences is "GENF."

What Is the Genflow Biosciences Market Cap?

As of today, Genflow Biosciences market cap is 11.47M GBP.

What Is Genflow Biosciences's Earnings Per Share (TTM)?

The Genflow Biosciences EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is GENF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genflow Biosciences Stock Split?

Genflow Biosciences has split 0 times.

How Many Employees Does Genflow Biosciences Have?

Genflow Biosciences has 5 employees.

What is the current trading status of Genflow Biosciences (GENF)?

As of Jul 09, 2026, Genflow Biosciences (GENF) is trading at a price of 2.03 GBP, with a previous close of 2.03 GBP. The stock has fluctuated within a day range of 1.96 GBP to 2.06 GBP, while its 52-week range spans from 0.55 GBP to 3.12 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.